Literature DB >> 25789099

Endoscopic treatment of difficult extrahepatic bile duct stones, EPBD or EST: An anatomic view.

Jun Ding1, Fu Li1, Hong-Yi Zhu1, Xi-Wen Zhang1.   

Abstract

Large bile duct stone (> 10 mm) or multiple stones (≥ 3) are challenging for endoscopists. Endoscopic sphincterotomy (EST) is a routine therapeutic endoscopic retrograde cholangiopancreatography (ERCP) procedure usually used. It is safe and effective, but severe perforation or massive bleeding are the main causes of mortality. Because of the permanent destroy of Oddi sphincter, the use of EST is still controversial. Endoscopic papillary balloon dilation (EPBD) gives another way to open the sphincter. Less incidence of bleeding, perforation and partly preserving the Oddi sphincter's function are the main advantages. But high incidence of post-ERCP pancreatitis becomes a predominant problem. According to the anatomical feature of Oddi sphincter, limited EST + EPBD seems a more reasonable procedure. Compared to the former two procedures, it makes the stone extraction process much easier with lower incidences of short-term and long-term complications.

Entities:  

Keywords:  Common bile duct stone; Endoscopic papillary balloon dilation; Endoscopic retrograde cholangiopancreatography; Endoscopic sphincterotomy

Year:  2015        PMID: 25789099      PMCID: PMC4360447          DOI: 10.4253/wjge.v7.i3.274

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  12 in total

1.  Large-balloon dilation of the sphincter of Oddi after sphincterotomy or infundibulotomy to extract large calculi or multiple common bile duct stones without using mechanical lithotripsy.

Authors:  Laurent Poincloux; Olivier Rouquette; Jocelyn Privat; Daniel Gorce; Armand Abergel; Michel Dapoigny; Gilles Bommelaer
Journal:  Scand J Gastroenterol       Date:  2012-01-10       Impact factor: 2.423

2.  Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.

Authors:  James A Disario; Martin L Freeman; David J Bjorkman; Padraic Macmathuna; Bret T Petersen; Philip E Jaffe; Thomas G Morales; Lee J Hixson; Stuart Sherman; Glen A Lehman; M Mazen Jamal; Firas H Al-Kawas; Mukul Khandelwal; Joseph P Moore; Gregory A Derfus; Priya A Jamidar; Francisco C Ramirez; Michael E Ryan; Karen L Woods; David L Carr-Locke; Stephen C Alder
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

3.  Large balloon dilation vs. mechanical lithotripsy for the management of large bile duct stones: a prospective randomized study.

Authors:  G Stefanidis; N Viazis; D Pleskow; S Manolakopoulos; L Theocharis; C Christodoulou; N Kotsikoros; J Giannousis; S Sgouros; M Rodias; A Katsikani; R Chuttani
Journal:  Am J Gastroenterol       Date:  2010-11-02       Impact factor: 10.864

4.  Long-term prognosis of bile duct stones: endoscopic papillary balloon dilatation versus endoscopic sphincterotomy.

Authors:  Yuko Kojima; Hiroshi Nakagawa; Akihiro Miyata; Takanori Hirai; Itaru Ohyama; Akihisa Okada; Takeshi Hiramatsu; Yasuji Ohhara; Takamichi Kuwahara
Journal:  Dig Endosc       Date:  2010-01       Impact factor: 7.559

5.  Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis.

Authors:  Naminatsu Takahara; Hiroyuki Isayama; Takashi Sasaki; Takeshi Tsujino; Nobuo Toda; Naoki Sasahira; Suguru Mizuno; Kazumichi Kawakubo; Hirofumi Kogure; Natsuyo Yamamoto; Yousuke Nakai; Kenji Hirano; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-02-22       Impact factor: 7.527

6.  Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series.

Authors:  Soo Jung Park; Jin Hong Kim; Jae Chul Hwang; Ho Gak Kim; Don Haeng Lee; Seok Jeong; Sang-Woo Cha; Young Deok Cho; Hong Ja Kim; Jong Hyeok Kim; Jong Ho Moon; Sang-Heum Park; Takao Itoi; Hiroyuki Isayama; Hirofumi Kogure; Se Joon Lee; Kyo Tae Jung; Hye Sun Lee; Todd H Baron; Dong Ki Lee
Journal:  Dig Dis Sci       Date:  2012-12-08       Impact factor: 3.199

7.  Endoscopic papillary balloon dilation for removal of bile duct stones: evaluation of outcomes and complications in 298 patients.

Authors:  Chung-Mou Kuo; Yi-Chun Chiu; Chi-Sin Changchien; Wen-Chen Tai; Seng-Kee Chuah; Tsung-Hui Hu; Yuan-Hung Kuo; Chung-Huang Kuo
Journal:  J Clin Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 3.062

8.  Papillary balloon dilation is not itself a cause of post-endoscopic retrograde cholangiopancreatography pancreatitis; results of anterograde and retrograde papillary balloon dilation.

Authors:  Yu Ri Seo; Jong Ho Moon; Hyun Jong Choi; Dong Choon Kim; Tae Hoon Lee; Sang-Woo Cha; Young Deok Cho; Sang-Heum Park; Sun-Joo Kim
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

9.  The increase in balloon size to over 15 mm does not affect the development of pancreatitis after endoscopic papillary large balloon dilatation for bile duct stone removal.

Authors:  Young Hoon Youn; Hyun Chul Lim; Jae Hoon Jahng; Sung Il Jang; Jung Hwan You; Jung Soo Park; Se Joon Lee; Dong Ki Lee
Journal:  Dig Dis Sci       Date:  2010-10-14       Impact factor: 3.199

10.  Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones.

Authors:  Hoi-Hung Chan; Kwok-Hung Lai; Chiun-Ku Lin; Wei-Lun Tsai; E-Ming Wang; Ping-I Hsu; Wen-Chi Chen; Hsien-Chung Yu; Huay-Min Wang; Feng-Woei Tsay; Cheng-Chung Tsai; I-Shu Chen; Yu-Chia Chen; Huei-Lung Liang; Huay-Ben Pan
Journal:  BMC Gastroenterol       Date:  2011-06-13       Impact factor: 3.067

View more
  7 in total

1.  Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria.

Authors:  Hongzhang Shen; Fuqiang Ye; Lu Xie; Jianfeng Yang; Zhen Li; Peisong Xu; Fei Meng; Lei Li; Ying Chen; Xiaochen Bo; Ming Ni; Xiaofeng Zhang
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

2.  Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones.

Authors:  Christos Konstantakis; Christos Triantos; Vasileios Theopistos; Georgios Theocharis; Ioannis Maroulis; Georgia Diamantopoulou; Konstantinos Thomopoulos
Journal:  World J Gastrointest Endosc       Date:  2017-01-16

3.  Endoscopic papillary balloon dilation decreases the risk of bleeding in cirrhotic patients compared with endoscopic biliary sphincterotomy: A national population-based study.

Authors:  Tsung-Hsing Hung; Chih-Wei Tseng; Yen-Chun Chen; Kuo-Chih Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 4.  Best Procedure for the Management of Common Bile Duct Stones via the Papilla: Literature Review and Analysis of Procedural Efficacy and Safety.

Authors:  Shigeto Ishii; Hiroyuki Isayama; Mako Ushio; Sho Takahashi; Wataru Yamagata; Yusuke Takasaki; Akinori Suzuki; Kazushige Ochiai; Ko Tomishima; Ryo Kanazawa; Hiroaki Saito; Toshio Fujisawa; Shuichiro Shiina
Journal:  J Clin Med       Date:  2020-11-25       Impact factor: 4.241

5.  Evaluation of the safety and efficacy of minimal endoscopic sphincterotomy followed by papillary balloon dilation for the removal of common bile duct stones.

Authors:  Shigeto Ishii; Toshio Fujisawa; Mako Ushio; Sho Takahashi; Wataru Yamagata; Yusuke Takasaki; Akinori Suzuki; Yoshihiro Okawa; Kazushige Ochiai; Ko Tomishima; Ryo Kanazawa; Hiroaki Saito; Shuichiro Shiina; Hiroyuki Isayama
Journal:  Saudi J Gastroenterol       Date:  2020-07-21       Impact factor: 2.485

Review 6.  The therapeutic effect of balloon dilatation with different duration for biliary duct calculi: A network meta-analysis.

Authors:  Zhi Yuan Yu; Chen Liang; Shi Yu Yang; Xu Zhang; Yan Sun
Journal:  J Minim Access Surg       Date:  2022 Jul-Sep       Impact factor: 1.018

7.  Modified percutaneous transhepatic papillary balloon dilation for patients with refractory hepatolithiasis.

Authors:  Bin Liu; Pi-Kun Cao; Yong-Zheng Wang; Wu-Jie Wang; Shi-Lin Tian; Yancu Hertzanu; Yu-Liang Li
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.